Ամանտադին (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ամանտադին" in Armenian language version.

refsWebsite

Global rank Armenian rank

33nih.gov

4^th place

3^rd place

17doi.org

2^nd place

4^th place

5semanticscholar.org

11^th place

428^th place

3tga.gov.au

3,984^th place

1,282^nd place

3archive.org

6^th place

2cdc.gov

218^th place

51^st place

2harvard.edu

18^th place

38^th place

2drugs.com

399^th place

102^nd place

1web.archive.org

1^st place

1who.int

195^th place

49^th place

1worldcat.org

5^th place

10^th place

1fda.gov

447^th place

244^th place

1medlineplus.gov

1,581^st place

470^th place

1drugbank.ca

4,294^th place

5,404^th place

1ebi.ac.uk

5,849^th place

1,555^th place

1handle.net

102^nd place

2,318^th place

1springer.com

274^th place

266^th place

archive.org

Golan DE, Armstrong EJ, Armstrong AW (2017). Principles of pharmacology: the pathophysiologic basis of drug therapy (4th ed.). Philadelphia: Wolters Kluwer. էջեր 142, 199, 205t, 224t, 608, 698–700. ISBN 9781451191004. OCLC 914593652.
Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization (WHO). էջ 242. hdl:10665/44053. ISBN 978-9241547659.
Tarsy D, Parkes JD, Marsden CD (1975 թ․ ապրիլ). «Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias». Journal of Neurology, Neurosurgery, and Psychiatry. 38 (4): 331–335. doi:10.1136/jnnp.38.4.331. PMC 491929. PMID 1095689.

cdc.gov

«Influenza Antiviral Medications: Summary for Clinicians». U.S. Centers for Disease Control and Prevention (CDC). 2019 թ․ ապրիլի 17. Վերցված է 2019 թ․ հուլիսի 14-ին.
«Seasonal Influenza (Flu) – Weekly Report: Influenza Summary Update». U.S. Centers for Disease Control and Prevention (CDC). 2009 թ․ սեպտեմբերի 5.

doi.org

James SH, Whitley RJ (2017). «Influenza Viruses». Infectious Diseases. Elsevier. էջեր 1465–1471.e1. doi:10.1016/b978-0-7020-6285-8.00172-6. ISBN 978-0-7020-6285-8.
Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer TA, Shimizu Y, և այլք: (2013 թ․ փետրվարի 1). Bouvier NM (ed.). «Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay». PLOS ONE. 8 (2): e55271. Bibcode:2013PLoSO...855271B. doi:10.1371/journal.pone.0055271. PMC 3562233. PMID 23383318.
Hubsher G, Haider M, Okun MS (2012 թ․ ապրիլ). «Amantadine: the journey from fighting flu to treating Parkinson disease». Neurology. 78 (14): 1096–9. doi:10.1212/WNL.0b013e31824e8f0d. PMID 22474298. S2CID 21515610.
Kumar B, Asha K, Khanna M, Ronsard L, Meseko CA, Sanicas M (2018 թ․ ապրիլ). «The emerging influenza virus threat: status and new prospects for its therapy and control». Archives of Virology. 163 (4): 831–844. doi:10.1007/s00705-018-3708-y. PMC 7087104. PMID 29322273.
Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P (1991 թ․ ապրիլ). «Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study». European Journal of Pharmacology. 206 (4): 297–300. doi:10.1016/0922-4106(91)90113-v. PMID 1717296.
Blanpied TA, Clarke RJ, Johnson JW (2005 թ․ մարտ). «Amantadine inhibits NMDA receptors by accelerating channel closure during channel block». The Journal of Neuroscience. 25 (13): 3312–22. doi:10.1523/JNEUROSCI.4262-04.2005. PMC 6724906. PMID 15800186.
Strömberg U, Svensson TH (1971 թ․ նոյեմբեր). «Further studies on the mode of action of amantadine». Acta Pharmacologica et Toxicologica. 30 (3): 161–71. doi:10.1111/j.1600-0773.1971.tb00646.x. PMID 5171936.
Peeters M, Romieu P, Maurice T, Su TP, Maloteaux JM, Hermans E (2004 թ․ ապրիլ). «Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine». The European Journal of Neuroscience. 19 (8): 2212–20. doi:10.1111/j.0953-816X.2004.03297.x. PMID 15090047. S2CID 19479968.
Thomaston JL, Alfonso-Prieto M, Woldeyes RA, Fraser JS, Klein ML, Fiorin G, DeGrado WF (2015 թ․ նոյեմբեր). «High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction». Proceedings of the National Academy of Sciences of the United States of America. 112 (46): 14260–5. Bibcode:2015PNAS..11214260T. doi:10.1073/pnas.1518493112. PMC 4655559. PMID 26578770.
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M (2017 թ․ ապրիլի 20). «Drug resistance in influenza A virus: the epidemiology and management». Infection and Drug Resistance. 10: 121–134. doi:10.2147/idr.s105473. PMC 5404498. PMID 28458567.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Deleu D, Northway MG, Hanssens Y (2002). «Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease». Clinical Pharmacokinetics. 41 (4): 261–309. doi:10.2165/00003088-200241040-00003. PMID 11978145. S2CID 39359348.
Rascol O, Fabbri M, Poewe W (2021 թ․ դեկտեմբեր). «Amantadine in the treatment of Parkinson's disease and other movement disorders». The Lancet. Neurology. 20 (12): 1048–1056. doi:10.1016/s1474-4422(21)00249-0. PMID 34678171. S2CID 239031883.
Crosby NJ, Deane KH, Clarke CE, և այլք: (Cochrane Movement Disorders Group) (2003 թ․ ապրիլի 22). «Amantadine for dyskinesia in Parkinson's disease». The Cochrane Database of Systematic Reviews. 2010 (2): CD003467. doi:10.1002/14651858.CD003467. PMC 8715285. PMID 12804468.
Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ, և այլք: (Cochrane Acute Respiratory Infections Group) (2014 թ․ նոյեմբեր). «Amantadine and rimantadine for influenza A in children and the elderly». The Cochrane Database of Systematic Reviews. 2014 (11): CD002745. doi:10.1002/14651858.CD002745.pub4. PMC 7093890. PMID 25415374.
Bahrani E, Nunneley CE, Hsu S, Kass JS (2016 թ․ մարտ). «Cutaneous Adverse Effects of Neurologic Medications». CNS Drugs. 30 (3): 245–67. doi:10.1007/s40263-016-0318-7. PMID 26914914. S2CID 10560952.
Vollum DI, Parkes JD, Doyle D (1971 թ․ հունիս). «Livedo reticularis during amantadine treatment». British Medical Journal. 2 (5762): 627–8. doi:10.1136/bmj.2.5762.627. PMC 1796527. PMID 5580722.
Tarsy D, Parkes JD, Marsden CD (1975 թ․ ապրիլ). «Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias». Journal of Neurology, Neurosurgery, and Psychiatry. 38 (4): 331–335. doi:10.1136/jnnp.38.4.331. PMC 491929. PMID 1095689.

drugbank.ca

«Amantadine». drugbank.ca. Վերցված է 2019 թ․ հուլիսի 13-ին.

drugs.com

«Amantadine Hydrochloride Monograph for Professionals». Drugs.com. Վերցված է 2020 թ․ նոյեմբերի 16-ին.
«Amantadine – FDA prescribing information, side effects and uses». Drugs.com. Վերցված է 2020 թ․ նոյեմբերի 16-ին.

ebi.ac.uk

«Rimantadine hydrochloride (CHEBI:8865)». ebi.ac.uk. Վերցված է 2019 թ․ հուլիսի 13-ին.

fda.gov

accessdata.fda.gov

«Symmetrel (Amantadine Hydrochloride, USP) fact sheet» (PDF). U.S. Food and Drug Administration (FDA). Վերցված է 2019 թ․ հուլիսի 28-ին.

handle.net

hdl.handle.net

Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization (WHO). էջ 242. hdl:10665/44053. ISBN 978-9241547659.

harvard.edu

ui.adsabs.harvard.edu

Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer TA, Shimizu Y, և այլք: (2013 թ․ փետրվարի 1). Bouvier NM (ed.). «Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay». PLOS ONE. 8 (2): e55271. Bibcode:2013PLoSO...855271B. doi:10.1371/journal.pone.0055271. PMC 3562233. PMID 23383318.
Thomaston JL, Alfonso-Prieto M, Woldeyes RA, Fraser JS, Klein ML, Fiorin G, DeGrado WF (2015 թ․ նոյեմբեր). «High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction». Proceedings of the National Academy of Sciences of the United States of America. 112 (46): 14260–5. Bibcode:2015PNAS..11214260T. doi:10.1073/pnas.1518493112. PMC 4655559. PMID 26578770.

medlineplus.gov

«Amantadine: MedlinePlus Drug Information». medlineplus.gov (անգլերեն). Վերցված է 2023 թ․ հունվարի 25-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer TA, Shimizu Y, և այլք: (2013 թ․ փետրվարի 1). Bouvier NM (ed.). «Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay». PLOS ONE. 8 (2): e55271. Bibcode:2013PLoSO...855271B. doi:10.1371/journal.pone.0055271. PMC 3562233. PMID 23383318.
Hubsher G, Haider M, Okun MS (2012 թ․ ապրիլ). «Amantadine: the journey from fighting flu to treating Parkinson disease». Neurology. 78 (14): 1096–9. doi:10.1212/WNL.0b013e31824e8f0d. PMID 22474298. S2CID 21515610.
Kumar B, Asha K, Khanna M, Ronsard L, Meseko CA, Sanicas M (2018 թ․ ապրիլ). «The emerging influenza virus threat: status and new prospects for its therapy and control». Archives of Virology. 163 (4): 831–844. doi:10.1007/s00705-018-3708-y. PMC 7087104. PMID 29322273.
Chang C, Ramphul K (2020). «Amantadine». StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763128. Վերցված է 2020 թ․ նոյեմբերի 2-ին.
Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P (1991 թ․ ապրիլ). «Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study». European Journal of Pharmacology. 206 (4): 297–300. doi:10.1016/0922-4106(91)90113-v. PMID 1717296.
Blanpied TA, Clarke RJ, Johnson JW (2005 թ․ մարտ). «Amantadine inhibits NMDA receptors by accelerating channel closure during channel block». The Journal of Neuroscience. 25 (13): 3312–22. doi:10.1523/JNEUROSCI.4262-04.2005. PMC 6724906. PMID 15800186.
Strömberg U, Svensson TH (1971 թ․ նոյեմբեր). «Further studies on the mode of action of amantadine». Acta Pharmacologica et Toxicologica. 30 (3): 161–71. doi:10.1111/j.1600-0773.1971.tb00646.x. PMID 5171936.
Peeters M, Romieu P, Maurice T, Su TP, Maloteaux JM, Hermans E (2004 թ․ ապրիլ). «Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine». The European Journal of Neuroscience. 19 (8): 2212–20. doi:10.1111/j.0953-816X.2004.03297.x. PMID 15090047. S2CID 19479968.
Thomaston JL, Alfonso-Prieto M, Woldeyes RA, Fraser JS, Klein ML, Fiorin G, DeGrado WF (2015 թ․ նոյեմբեր). «High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction». Proceedings of the National Academy of Sciences of the United States of America. 112 (46): 14260–5. Bibcode:2015PNAS..11214260T. doi:10.1073/pnas.1518493112. PMC 4655559. PMID 26578770.
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M (2017 թ․ ապրիլի 20). «Drug resistance in influenza A virus: the epidemiology and management». Infection and Drug Resistance. 10: 121–134. doi:10.2147/idr.s105473. PMC 5404498. PMID 28458567.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Deleu D, Northway MG, Hanssens Y (2002). «Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease». Clinical Pharmacokinetics. 41 (4): 261–309. doi:10.2165/00003088-200241040-00003. PMID 11978145. S2CID 39359348.
Rascol O, Fabbri M, Poewe W (2021 թ․ դեկտեմբեր). «Amantadine in the treatment of Parkinson's disease and other movement disorders». The Lancet. Neurology. 20 (12): 1048–1056. doi:10.1016/s1474-4422(21)00249-0. PMID 34678171. S2CID 239031883.
Crosby NJ, Deane KH, Clarke CE, և այլք: (Cochrane Movement Disorders Group) (2003 թ․ ապրիլի 22). «Amantadine for dyskinesia in Parkinson's disease». The Cochrane Database of Systematic Reviews. 2010 (2): CD003467. doi:10.1002/14651858.CD003467. PMC 8715285. PMID 12804468.
Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ, և այլք: (Cochrane Acute Respiratory Infections Group) (2014 թ․ նոյեմբեր). «Amantadine and rimantadine for influenza A in children and the elderly». The Cochrane Database of Systematic Reviews. 2014 (11): CD002745. doi:10.1002/14651858.CD002745.pub4. PMC 7093890. PMID 25415374.
Hosenbocus S, Chahal R (2013 թ․ փետրվար). «Amantadine: a review of use in child and adolescent psychiatry». Journal of the Canadian Academy of Child and Adolescent Psychiatry. 22 (1): 55–60. PMC 3565716. PMID 23390434.
Bahrani E, Nunneley CE, Hsu S, Kass JS (2016 թ․ մարտ). «Cutaneous Adverse Effects of Neurologic Medications». CNS Drugs. 30 (3): 245–67. doi:10.1007/s40263-016-0318-7. PMID 26914914. S2CID 10560952.
Vollum DI, Parkes JD, Doyle D (1971 թ․ հունիս). «Livedo reticularis during amantadine treatment». British Medical Journal. 2 (5762): 627–8. doi:10.1136/bmj.2.5762.627. PMC 1796527. PMID 5580722.
Tarsy D, Parkes JD, Marsden CD (1975 թ․ ապրիլ). «Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias». Journal of Neurology, Neurosurgery, and Psychiatry. 38 (4): 331–335. doi:10.1136/jnnp.38.4.331. PMC 491929. PMID 1095689.

ncbi.nlm.nih.gov

Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer TA, Shimizu Y, և այլք: (2013 թ․ փետրվարի 1). Bouvier NM (ed.). «Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay». PLOS ONE. 8 (2): e55271. Bibcode:2013PLoSO...855271B. doi:10.1371/journal.pone.0055271. PMC 3562233. PMID 23383318.
Kumar B, Asha K, Khanna M, Ronsard L, Meseko CA, Sanicas M (2018 թ․ ապրիլ). «The emerging influenza virus threat: status and new prospects for its therapy and control». Archives of Virology. 163 (4): 831–844. doi:10.1007/s00705-018-3708-y. PMC 7087104. PMID 29322273.
Chang C, Ramphul K (2020). «Amantadine». StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763128. Վերցված է 2020 թ․ նոյեմբերի 2-ին.
«Amantadine – MeSH». NCBI.
Blanpied TA, Clarke RJ, Johnson JW (2005 թ․ մարտ). «Amantadine inhibits NMDA receptors by accelerating channel closure during channel block». The Journal of Neuroscience. 25 (13): 3312–22. doi:10.1523/JNEUROSCI.4262-04.2005. PMC 6724906. PMID 15800186.
Thomaston JL, Alfonso-Prieto M, Woldeyes RA, Fraser JS, Klein ML, Fiorin G, DeGrado WF (2015 թ․ նոյեմբեր). «High-resolution structures of the M2 channel from influenza A virus reveal dynamic pathways for proton stabilization and transduction». Proceedings of the National Academy of Sciences of the United States of America. 112 (46): 14260–5. Bibcode:2015PNAS..11214260T. doi:10.1073/pnas.1518493112. PMC 4655559. PMID 26578770.
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M (2017 թ․ ապրիլի 20). «Drug resistance in influenza A virus: the epidemiology and management». Infection and Drug Resistance. 10: 121–134. doi:10.2147/idr.s105473. PMC 5404498. PMID 28458567.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Crosby NJ, Deane KH, Clarke CE, և այլք: (Cochrane Movement Disorders Group) (2003 թ․ ապրիլի 22). «Amantadine for dyskinesia in Parkinson's disease». The Cochrane Database of Systematic Reviews. 2010 (2): CD003467. doi:10.1002/14651858.CD003467. PMC 8715285. PMID 12804468.
Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ, և այլք: (Cochrane Acute Respiratory Infections Group) (2014 թ․ նոյեմբեր). «Amantadine and rimantadine for influenza A in children and the elderly». The Cochrane Database of Systematic Reviews. 2014 (11): CD002745. doi:10.1002/14651858.CD002745.pub4. PMC 7093890. PMID 25415374.
Hosenbocus S, Chahal R (2013 թ․ փետրվար). «Amantadine: a review of use in child and adolescent psychiatry». Journal of the Canadian Academy of Child and Adolescent Psychiatry. 22 (1): 55–60. PMC 3565716. PMID 23390434.
Vollum DI, Parkes JD, Doyle D (1971 թ․ հունիս). «Livedo reticularis during amantadine treatment». British Medical Journal. 2 (5762): 627–8. doi:10.1136/bmj.2.5762.627. PMC 1796527. PMID 5580722.
Tarsy D, Parkes JD, Marsden CD (1975 թ․ ապրիլ). «Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias». Journal of Neurology, Neurosurgery, and Psychiatry. 38 (4): 331–335. doi:10.1136/jnnp.38.4.331. PMC 491929. PMID 1095689.

dailymed.nlm.nih.gov

«Gocovri- amantadine capsule, coated pellets». DailyMed. 2019 թ․ դեկտեմբերի 26. Վերցված է 2020 թ․ հունվարի 22-ին.
«Gocovri- amantadine capsule, coated pellets». DailyMed. 2019 թ․ դեկտեմբերի 26. Վերցված է 2020 թ․ հունվարի 22-ին.

pubchem.ncbi.nlm.nih.gov

«Amantadine». PubChem. U.S. Library of Medicine. Վերցված է 2019 թ․ հուլիսի 29-ին.

semanticscholar.org

api.semanticscholar.org

Hubsher G, Haider M, Okun MS (2012 թ․ ապրիլ). «Amantadine: the journey from fighting flu to treating Parkinson disease». Neurology. 78 (14): 1096–9. doi:10.1212/WNL.0b013e31824e8f0d. PMID 22474298. S2CID 21515610.
Peeters M, Romieu P, Maurice T, Su TP, Maloteaux JM, Hermans E (2004 թ․ ապրիլ). «Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine». The European Journal of Neuroscience. 19 (8): 2212–20. doi:10.1111/j.0953-816X.2004.03297.x. PMID 15090047. S2CID 19479968.
Deleu D, Northway MG, Hanssens Y (2002). «Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease». Clinical Pharmacokinetics. 41 (4): 261–309. doi:10.2165/00003088-200241040-00003. PMID 11978145. S2CID 39359348.
Rascol O, Fabbri M, Poewe W (2021 թ․ դեկտեմբեր). «Amantadine in the treatment of Parkinson's disease and other movement disorders». The Lancet. Neurology. 20 (12): 1048–1056. doi:10.1016/s1474-4422(21)00249-0. PMID 34678171. S2CID 239031883.
Bahrani E, Nunneley CE, Hsu S, Kass JS (2016 թ․ մարտ). «Cutaneous Adverse Effects of Neurologic Medications». CNS Drugs. 30 (3): 245–67. doi:10.1007/s40263-016-0318-7. PMID 26914914. S2CID 10560952.

springer.com

link.springer.com

Bahrani E, Nunneley CE, Hsu S, Kass JS (2016 թ․ մարտ). «Cutaneous Adverse Effects of Neurologic Medications». CNS Drugs. 30 (3): 245–67. doi:10.1007/s40263-016-0318-7. PMID 26914914. S2CID 10560952.

tga.gov.au

ebs.tga.gov.au

«Symmetrel (amantadine hydrochloride)» (PDF). TGA eBusiness Services. Novartis Pharmaceuticals Australia Pty Limited. 2011 թ․ հունիսի 29. Վերցված է 2014 թ․ փետրվարի 24-ին.
«Australian Product Information – Symmetrel (Amantadine Hydrochloride) Capsules». Australian Department of Health Therapeutic Goods Administration. Վերցված է 2019 թ․ հուլիսի 13-ին.
«TGA eBS - Product and Consumer Medicine Information Licence». {{cite journal}}: Cite journal requires |journal= (օգնություն)

web.archive.org

«Summary of influenza antiviral susceptibility surveillance findings». World Health Organization (WHO). September 2010 – March 2011. Արխիվացված է օրիգինալից 2017 թ․ հուլիսի 27-ին. Վերցված է 2019 թ․ հուլիսի 19-ին.

who.int

«Summary of influenza antiviral susceptibility surveillance findings». World Health Organization (WHO). September 2010 – March 2011. Արխիվացված է օրիգինալից 2017 թ․ հուլիսի 27-ին. Վերցված է 2019 թ․ հուլիսի 19-ին.

worldcat.org

Golan DE, Armstrong EJ, Armstrong AW (2017). Principles of pharmacology: the pathophysiologic basis of drug therapy (4th ed.). Philadelphia: Wolters Kluwer. էջեր 142, 199, 205t, 224t, 608, 698–700. ISBN 9781451191004. OCLC 914593652.